iSOFT Hosts Forum to Discuss Future Role of eClinical Trial Technologies

iSOFTiSOFT recently hosted the eClinical Forum to discuss how existing and emerging healthcare environments impact on clinical trials, and the future role of eClinical trial technologies.

The eClinical Forum was formed in 2000 by Pharmaceutical industry representatives with a vision to create a non-commercial and informal environment in which to network with peers, share ideas and experiences, and to shape the future of the clinical research environment.

The meeting was held at iSOFT's headquarters and was opened by iSOFT chief executive Andrea Fiumicelli who explained that despite the enormous progresses made, much needed to be done to improve the delivery of healthcare, and in particular improve safety through better use of information systems.

The clinical trial process was a key focus of the session. Identifying eligible patients for clinical trials is a constant challenge, and 58 per cent of clinical trials fail to achieve their recruitment targets. Dr Joerg Kraenzlein, director of life science at iSOFT described a system which is being developed to help investigators and pharmaceuticals companies conduct clinical trials more easily. "We want to build a network for physicians to collaborate, foster the use of personalised medicine and the production of clinical trials helping to speed up the process," he explained.

In the iSOFT system under development, patient records are de-identified and medical terms extracted to create the AccelCDB (Clinical Database). The investigator can then use the AccelFind web base application to identify suitable patients for the trial by defining the inclusion and exclusion criteria.

"It just takes 5 to 10 seconds to screen 10,000 medical records, whereas with a manual process a physician has to work for weeks," Dr Kraenzlein said.

The forum agreed that there is an urgent need for an integrated solution for research activities to increase efficiency while maintaining a high level of quality. This will help shorten the clinical trial process and ultimately assist in bringing drugs to market in a more timely way.

Related news articles:

About iSOFT a CSC company
Headquartered in Banbury, UK, iSOFT is one of the world's largest healthcare IT companies serving 13,000 healthcare providers in over 40 countries across five continents. Its software product portfolio is one of the most extensive available, covering every aspect of healthcare delivery and planning. These include interoperable e-health solutions that build on existing systems to maximize current investments.

iSOFT's business is driven by the collective talent, experience and commitment of over 3,000 specialists in 19 countries. Through a global network of subsidiaries and extensive partner network, iSOFT also has substantial experience of national healthcare sectors and expert knowledge of local market needs.

iSOFT is a CSC Company.

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

AI-Based App can Help Physicians Find Sk…

A mobile app that uses artificial intelligence, AI, to analyse images of suspected skin lesions can diagnose melanoma with very high precision. This is shown in a study led from...

Powerful New AI can Predict People'…

A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...